The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
_256_384.jpg)
The much-awaited drone delivery trials for the delivery of medicines and vaccines will be held in Vikarabad, Hyderabad from 9th September till 17th October.
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Subscribe To Our Newsletter & Stay Updated
